| | |||||||
| finance | |||||||
| NEWS | |||||||
FDA Approves Empagliflozin for Broader Type of Heart Failure Jardiance (empagliflozin) received approval from the FDA for a new indication to treat heart failure in a broader range of patients, including those with preserved ejection fraction. This story has been updated. The FDA today approved the use of Eli ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment